30 08, 2016 Giorgia Gurioli et al., Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of Translational Medicine Diatech Pharmacogenetics2017-08-08T12:44:23+02:00 Read More
30 08, 2016 Lorenzo Gerratana et al., Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy Diatech Pharmacogenetics2017-08-07T11:23:58+02:00 Read More
21 08, 2016 Roberto Moretto et al., Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist Diatech Pharmacogenetics2016-08-21T11:46:30+02:00 Read More
26 07, 2016 “Print-Age” An integrated approach for the promotion of health of old and fragile people: infections prevention, nutritional integration and personalized therapy Diatech Pharmacogenetics2017-08-21T10:43:11+02:00 Read More
7 07, 2016 Maria Rosaria Raspollini et al., Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study. APMIS Diatech Pharmacogenetics2016-07-07T12:29:43+02:00 Read More
7 07, 2016 Andrea Casadei Gardini et al., Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:42:00+02:00 Read More
7 07, 2016 Rossella Bruno et al., Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction. Molecular Medicine Reports Diatech Pharmacogenetics2016-07-07T12:14:12+02:00 Read More
3 07, 2016 Filippo Martignano et al., GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Disease Markers Diatech Pharmacogenetics2017-08-08T12:36:06+02:00 Read More
14 06, 2016 Riccardo Giannini et al., EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center. Oncology Reports Diatech Pharmacogenetics2017-08-08T12:43:22+02:00 Read More
3 06, 2016 Maria Rosaria Raspolini et al., Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma. Journal of Clinical Pathology Diatech Pharmacogenetics2017-08-07T12:44:12+02:00 Read More
